AbbVie (NYSE: ABBV) and Neomorph, Inc. today announced a collaboration and option-to-license agreement to develop novel molecular glue degraders for multiple targets across oncology and immunology.
President Donald Trump made billions of dollars from the launch of his own crypto token within the three days before his inauguration, but he didn’t know until a reporter told him.